Rogers, Jonathan P;
Oldham, Mark A;
Fricchione, Gregory;
Northoff, Georg;
Ellen Wilson, Jo;
Mann, Stephan C;
Francis, Andrew;
... David, Anthony S; + view all
(2023)
Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology.
Journal of Psychopharmacology
, 37
(4)
pp. 327-369.
10.1177/02698811231158232.
Preview |
Text (Published article)
02698811231158232.pdf Download (783kB) | Preview |
Preview |
Text
Rogers_Suppl Mat 1 - List of recommendations 2.1.pdf Download (137kB) | Preview |
Preview |
Text
Rogers_Suppl Mat 2 - BAP catatonia plain language summary.pdf Download (84kB) | Preview |
![[thumbnail of Suppl Mat 3 - Presentation slides for BAP catatonia guideline 2.0.pptx]](https://discovery.ucl.ac.uk/style/images/fileicons/text.png) |
Text
Suppl Mat 3 - Presentation slides for BAP catatonia guideline 2.0.pptx - Supplemental Material Download (335MB) |
Preview |
Text
Figure 1 - BAP catatonia algorithm 2.1.pdf - Supplemental Material Download (79kB) | Preview |
Abstract
The British Association for Psychopharmacology developed an evidence-based consensus guideline on the management of catatonia. A group of international experts from a wide range of disciplines was assembled. Evidence was gathered from existing systematic reviews and the primary literature. Recommendations were made on the basis of this evidence and were graded in terms of their strength. The guideline initially covers the diagnosis, aetiology, clinical features and descriptive epidemiology of catatonia. Clinical assessments, including history, physical examination and investigations are then considered. Treatment with benzodiazepines, electroconvulsive therapy and other pharmacological and neuromodulatory therapies is covered. Special regard is given to periodic catatonia, malignant catatonia, neuroleptic malignant syndrome and antipsychotic-induced catatonia. There is attention to the needs of particular groups, namely children and adolescents, older adults, women in the perinatal period, people with autism spectrum disorder and those with certain medical conditions. Clinical trials were uncommon, and the recommendations in this guideline are mainly informed by small observational studies, case series and case reports, which highlights the need for randomised controlled trials and prospective cohort studies in this area.
| Type: | Article |
|---|---|
| Title: | Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1177/02698811231158232 |
| Publisher version: | https://doi.org/10.1177/02698811231158232 |
| Language: | English |
| Additional information: | Copyright © The Author(s) 2023. This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| Keywords: | Catatonia, benzodiazepine, catatonic schizophrenia, electroconvulsive therapy, guideline, neuroleptic malignant syndrome, treatment |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Division of Psychiatry UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Division of Psychiatry > Institute of Mental Health |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10168158 |
Archive Staff Only
 |
View Item |
